UPDATE 2-Nektar withdraws application for opioid painkiller after FDA panel's vote
January 14, 2020 at 23:50 PM EST
Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration (FDA) panel unanimously voted against the drug's approval.